Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meal-time Exenatide for Glycaemic Control in Type 1 Diabetes
2016-001365-92Phase 2Completed
- Sponsor
- Center for Diabetes Research
- Start
- Jul 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Exenatide add-on arm with Placebo add-on arm (2 arms). Primary endpoint: Change in HbA1c from baseline to 26 weeks. Started Jul 2016; status: completed.
02
Drugs
exenatide
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2016-001365-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001365-92.